^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Vartrace® BRAF Panel

Company:
NuProbe
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
NuProbe’s VarTrace™ BRAF Assay detects and quantifies actionable BRAF mutations including V600E/K/R, L597P/Q/R/S, and K601E down to 0.1% VAF, requiring 10 – 100 ng cell-free DNA from blood plasma or 10 – 1000 ng DNA from tissue biopsy.
Cancer:
Colorectal Cancer, Melanoma, Thyroid Gland Papillary Carcinoma
Gene:
BRAF (B-raf proto-oncogene)
Drug:
Zelboraf (vemurafenib)
Method:
PCR